Qiagen NV (NYSE:QGEN)

34.21
Delayed Data
As of Feb 16
 +0.41 / +1.21%
Today’s Change
27.74
Today|||52-Week Range
36.34
+10.60%
Year-to-Date
QIAGEN's QFT-Plus Approval in Japan to Expand Customer Base
Feb 12 / Zacks.com - Paid Partner Content
QIAGEN Strong on Molecular Diagnostics, Competition Rife
Feb 09 / Zacks.com - Paid Partner Content